EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacist-led harm reduction outreach for veterans who inject drugs: A quality improvement evaluation

Michelle Tang, Jennifer Armentrout-Jones, Tessa Lynne Rife-Pennington

INNOVATIONS in pharmacy · 03.03.2026 · 16 (4)

DOI: 10.24926/iip.v16i4.6978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INNOVATIONS in pharmacy, online erschienen am 03.03.2026. Verfasst von Michelle Tang und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Injection drug use (IDU) increases risk for preventable infections and drug overdose. Within the Veterans Health Administration, dedicated syringe services programs (SSP) aim to reduce these harms; however, identifying and engaging Veterans with recent IDU remains challenging. This quality improvement (QI) project evaluated a clinical pharmacist practitioner (CPP)-led outreach model designed to increase SSP engagement and harm reduction resource access among Veterans with IDU receiving care at a single Veterans Affairs (VA) Health Care System.

Methods

This was a prospective single-arm cohort QI project completed July 2024-April 2025. Veterans with past-year IDU were identified via the national VA Syringe Service Program Dashboard and verified via retrospective chart review. A CPP-led team contacted Veterans by phone and in-person outreach, offered education, and provided harm reduction resources. The primary outcome was engagement with outreach; secondary outcomes included acceptance of infection screening, antimicrobial treatment/prophylaxis, and supplies for safer injection, infection prevention, safer sex, and overdose prevention. Descriptive statistics were used to evaluate results.

Results

Veterans (n=53) were age 57.6 ± 12.3 years, primarily assigned male at birth (n=51, 96.2%), unknown gender identity (n=32, 60.4%), White/Caucasian (n=27, 50.9%), and straight/heterosexual (n=31, 58.5%). Fourteen (26.4%) engaged with the CPP-led outreach. Among those, most (n=13, 92.9%) accepted ≥ 1 resource: supplies for overdose prevention (n=11, 78.6%), infection prevention (n=10, 71.4%), safer injection (n=9, 64.3%), and safer sex (n=4, 28.6%), plus infection screening (n=6, 42.9%) and hepatitis B virus vaccine (n=1, 7.1%). None accepted HIV pre-exposure prophylaxis. Among the remaining Veterans, 21 (39.6%) were not reached, 15 (28.3%) declined, and 3 (5.7%) were deceased.

Conclusion

Approximately one in four Veterans with past-year IDU engaged with the CPP-led team. Outreach resulted in new linkages to resources that reduce infection and overdose risk. These findings highlight the potential value of low barrier, dashboard-driven harm reduction outreach, and further evaluation is warranted.

Zitieren

APA

Tang, M., Armentrout-Jones, J., & Rife-Pennington, T. L. (2026). Pharmacist-led harm reduction outreach for veterans who inject drugs: A quality improvement evaluation. INNOVATIONS in pharmacy, 16(4). https://doi.org/10.24926/iip.v16i4.6978

Vancouver

Tang M, Armentrout-Jones J, Rife-Pennington TL. Pharmacist-led harm reduction outreach for veterans who inject drugs: A quality improvement evaluation. INNOVATIONS in pharmacy. 2026;16(4). doi:10.24926/iip.v16i4.6978

BibTeX
@article{Tang2026,
  author = {Tang, Michelle and Armentrout-Jones, Jennifer and Rife-Pennington, Tessa Lynne},
  title = {Pharmacist-led harm reduction outreach for veterans who inject drugs: A quality improvement evaluation},
  journal = {INNOVATIONS in pharmacy},
  year = {2026},
  volume = {16},
  number = {4},
  doi = {10.24926/iip.v16i4.6978}
}
Kostenlos starten →